MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Optimi Health Corp (CSE:OPTI)

0.2900 UNCHANGED
Streaming Delayed Price Updated: 2:52 PM EDT, Mar 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,115
Open 0.2900
Bid (Size) 0.2850 (4,000)
Ask (Size) 0.3000 (30,000)
Prev. Close 0.2900
Today's Range 0.2900 - 0.2950
52wk Range 0.1050 - 0.4200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
Vancouver, British Columbia-March 16, 2026 - Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FSE:8BN) (the "Company" or "Optimi"), a commercial-stage 
Via PressReach
Topics Regulatory Compliance
News headline image
Optimi Health Completes MD-MA Export for PTSD Treatment Under Australia’s Authorised Prescriber Scheme
(February 9, 2026) - Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmaceutical psychoactive 
Via PressReach

Performance

YTD
-7.9%
-7.9%
1 Month
-15.9%
-15.9%
3 Month
-17.1%
-17.1%
6 Month
-1.7%
-1.7%
1 Year
+52.6%
+52.6%

More News

Read More
News headline image
Optimi Health Completes First 2026 Production of MD-MA and Psilo Capsules
Via PressReach
News headline image
Early Warning Press Release in Accordance with National Instrument 62-103
Via Newsfile
Optimi Health Announces C$3.27 Million Private Placement with Strategic Investment from Lululemon Founder Chip Wilson
Via PressReach
News headline image
Psychedelic Drugs Prove Their Worth In Clinical Trials
Via PressReach
News headline image
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via PressReach
Topics Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via FinancialNewsMedia
Topics Cannabis
Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA
Via PressReach
Topics Supply Chain
Psychedelics May Make People Less Afraid of Death
Via FinancialNewsMedia
Topics Supply Chain
Psychedelics Use Among Young Adults Reaches All-Time High
Via FinancialNewsMedia
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
Via FinancialNewsMedia
Topics Supply Chain
Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market
Via FinancialNewsMedia
Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application
Via FinancialNewsMedia
Topics Intellectual Property
Rising Prevalence of Mental Depression & Anxiety Major Drivers Propelling Demand In Psychedelic Drugs Market
Via FinancialNewsMedia

Frequently Asked Questions

Is Optimi Health Corp publicly traded?
Yes, Optimi Health Corp is publicly traded.
What exchange does Optimi Health Corp trade on?
Optimi Health Corp trades on the Canadian Securities Exchange
What is the ticker symbol for Optimi Health Corp?
The ticker symbol for Optimi Health Corp is OPTI on the Canadian Securities Exchange
What is the current price of Optimi Health Corp?
The current price of Optimi Health Corp is 0.2900
When was Optimi Health Corp last traded?
The last trade of Optimi Health Corp was at 03/20/26 02:52 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story